Related Experiment Video
Updated: Dec 23, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Identification and early anticoagulation in patients with atrial fibrillation in the emergency department
Kim Schwab1, Richard Smith2, Eric Wager3
1Sharp Chula Vista Medical Center, Chula Vista, CA, United States of America.
Insights
A multidisciplinary team approach significantly improved guideline-recommended anticoagulation prescribing for atrial fibrillation patients in the emergency department, closing a critical treatment gap for stroke prevention.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Emergency departments (ED) encounter over 500,000 atrial fibrillation (AF) visits annually in the US.
- Guideline-recommended anticoagulation is underprescribed in less than 55% of eligible AF patients.
- A significant treatment gap exists in anticoagulation therapy for AF patients presenting to the ED.
Purpose of the Study:
- To measure guideline-recommended anticoagulation prescribing in nonvalvular atrial fibrillation (NVAF) patients in the ED.
- To assess the effectiveness of a multidisciplinary team approach in closing the anticoagulation treatment gap.
- To compare anticoagulation prescribing between routine care and a multidisciplinary team intervention.
Main Methods:
- An observational, prospective cohort study design was employed.
- CHA2DS2-VASc and HAS-BLED scores determined guideline-based oral anticoagulation (OAC) compliance.
- A multidisciplinary team approach with Transition of Care (TOC) services was compared to routine care (baseline cohort).
Main Results:
- Guideline-based OAC discharge rates were 62.3% in the baseline cohort (n=99) versus 87.8% in the multidisciplinary team cohort (n=131).
- The multidisciplinary approach resulted in a 25.5% improvement in appropriate anticoagulation prescribing (p < .001).
- This improvement was statistically significant, with a 95% confidence interval of (0.14-0.37).
Conclusions:
- A multidisciplinary team approach, including TOC services, enhances identification and early intervention for NVAF patients at stroke risk in the ED.
- This strategy significantly increases the proportion of moderate to high-risk patients discharged with guideline-based OAC.
- Implementing such a team approach can effectively close the treatment gap in anticoagulation for NVAF patients.
Background:
Emergency departments (ED) in the United States see more than half a million atrial fibrillation visits a year, however guideline recommended anticoagulation is prescribed in <55% of eligible patients.
Objective:
The purpose of this study was to measure guideline recommended anticoagulation prescribing in patients with nonvalvular atrial fibrillation (NVAF) presenting to the ED, with the goal of closing any treatment gap established.
Methods:
We conducted an observational, prospective cohort study in consecutive patients presenting to the ED with a diagnosis of NVAF. CHA2DS2-VASc and HAS-BLED scores were calculated and used as predefined criteria to establish guideline-based oral anticoagulation compliance in comparing routine care (baseline cohort) versus a multidisciplinary team approach. Transition of Care (TOC) services and follow-up were also provided in the multidisciplinary cohort. The primary endpoint was to compare the proportion of patients on guideline based oral anticoagulant (OAC) therapy at admission and discharge between the groups.
Results:
In the Baseline Cohort (BC) (n = 99), 62.3% of patients with a moderate-high risk of stroke (CHA2DS2-VASc score ≥ 2) were discharged on guideline-based OAC therapy versus 87.8% in the Multidisciplinary Team Cohort (MTC) (n = 131), a 25.5% overall improvement for appropriate anticoagulation (p-value <.001, 95% CI (0.14-0.37)).
Conclusions:
A multidisciplinary team approach with TOC services for the identification and early intervention of NVAF patients at risk of stroke in the ED can significantly improve the percentage of moderate to high-risk patients that are discharged home with guideline based OAC.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome III: Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiopulmonary Resuscitation III: AED Use

